TruTrace signed a letter of intent to establish a strategic working relationship with Anandia, which is focused on science, genetics, and independent cannabis product testing. The two companies plan to collaborate on an integrated testing solution in relation to TruTrace’s development of a blockchain-based traceability ecosystem.
Under the agreement, Anandia will serve as a primary analytical and genetic testing partner in the TruTrace ecosystem. The parties will also explore ways to work together on rapidly expediting and optimizing the testing processes under the Cannabis Act (Canada) as set forth by Health Canada, as well as evolving genetic testing practices in the cannabis industry.
Anandia is also expected to be one of the featured testing facilities in the Shoppers Drug Mart and TruTrace medical cannabis verification pilot program. As announced by Shoppers at the second annual World Cannabis Congress, the pilot program is built on TruTrace’s StrainSecure platform, which focuses on testing and verification to confirm the origin, authenticity and quality assurance of cannabis products.
“Establishing a comprehensive traceability program is an important step for the cannabis industry in offering full transparency and verification for patients and consumers,” Anandia President and Co-Founder Dr. John Coleman stated. “We are supportive of these objectives and look forward to working with TruTrace, Shoppers and others in the Pilot Program.”